Individualized Fluid And Vasopressor Administration In Surgical Patients
INFIVASP
Individualized Fluid and Vasopressor Administration in Surgical Patients: A Randomized Controlled Trial
1 other identifier
interventional
38
1 country
1
Brief Summary
The purpose of this study is to compare two different strategies of intraoperative mean arterial pressure (MAP) and stroke volume index management in high-risk patients undergoing major abdominal and orthopedic surgery (manual versus automated) The investigators hypothesis is that the automated group will spend less time during surgery in hypotension (defined as a MAP\<90% of patient's MAP baseline) compared to the manual group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2019
CompletedFirst Posted
Study publicly available on registry
May 29, 2019
CompletedStudy Start
First participant enrolled
October 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2020
CompletedMarch 2, 2021
February 1, 2021
9 months
May 24, 2019
March 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of surgery time in hypotension
Percentage of surgery time in hypotension (defined as the percentage of case time the patient will spend with a MAP \< 10% of patient's MAP Baseline)
at day 1
Secondary Outcomes (1)
Postoperative complications incidence
at DAY 30
Study Arms (2)
Manual management of hypotension
ACTIVE COMPARATORFluid and vasopressor will be managed as standard practice ( manually infusion of both fluid and vasopressors) following the investigators manual individualized hemodynamic protocol.(objective being to keep both stroke volume and MAP within 90 % of the target values)
Automated management of hypotension
EXPERIMENTALFluid and vasopressor will be managed with a novel active clinical decision support system to guide fluid administration and automated closed-loop system to maintain MAP within 90% of patient' baseline.
Interventions
Fluid and vasopressor will be administered based on a novel automated clinical decision support system.
Eligibility Criteria
You may qualify if:
- All adult patients scheduled for major abdominal and orthopedic surgery equipped with a cardiac output monitoring device.
You may not qualify if:
- Patients \< 18 years old
- cardiac arrythmia (atrial fibrillation)
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bicetre Hospital
Le Kremlin-Bicêtre, 94270, France
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Joosten, MD PhD
Bicetre hospital, APHP.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2019
First Posted
May 29, 2019
Study Start
October 27, 2019
Primary Completion
July 26, 2020
Study Completion
July 26, 2020
Last Updated
March 2, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share